CN Patent

CN109331036A — 多糖铁在制备治疗高磷血症的药物中的应用

Assigned to Shanghai Pharmaceutical Group Qingdao Guofeng Pharmaceutical Co Ltd · Expires 2019-02-15 · 7y expired

What this patent protects

本发明公开了多糖铁在制备降低磷的药物中的应用，所述降低磷的药物是指治疗高磷血症的药物，所述降低磷的药物是指磷酸盐吸附剂。多糖铁的磷结合率和复方氢氧化铝片、碳酸钙D3片和碳酸镧咀嚼片的磷结合率有显著性差异(P＜0.01)，这说明在相同剂量下多糖铁降磷效果优于复方氢氧化铝片、碳酸钙D3片和碳酸镧咀嚼片。

USPTO Abstract

本发明公开了多糖铁在制备降低磷的药物中的应用，所述降低磷的药物是指治疗高磷血症的药物，所述降低磷的药物是指磷酸盐吸附剂。多糖铁的磷结合率和复方氢氧化铝片、碳酸钙D3片和碳酸镧咀嚼片的磷结合率有显著性差异(P＜0.01)，这说明在相同剂量下多糖铁降磷效果优于复方氢氧化铝片、碳酸钙D3片和碳酸镧咀嚼片。

Drugs covered by this patent

Patent Metadata

Patent number
CN109331036A
Jurisdiction
CN
Classification
—
Expires
2019-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pharmaceutical Group Qingdao Guofeng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.